Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 5,250 KRW
Change Today -40.00 / -0.76%
Volume 1.2M
005690 On Other Exchanges
Symbol
Exchange
Korea SE
As of 12:23 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

pharmicell co ltd (005690) Snapshot

Open
5,280
Previous Close
5,290
Day High
5,440
Day Low
5,170
52 Week High
07/28/15 - 7,550
52 Week Low
09/2/14 - 2,830
Market Cap
295.6B
Average Volume 10 Days
2.6M
EPS TTM
--
Shares Outstanding
56.3M
EX-Date
12/29/10
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PHARMICELL CO LTD (005690)

Related News

No related news articles were found.

pharmicell co ltd (005690) Related Businessweek News

No Related Businessweek News Found

pharmicell co ltd (005690) Details

PHARMICELL Co., Ltd., a biotechnology company, focuses on the development and commercialization of stem cell therapeutics in South Korea and internationally. It develops cardiac, nervous system, liver, and lung disorder drugs, as well as anti-cancer drugs. The company also operates Twelve adult, a stem cell bank that extracts and preserves bone marrow from adults for use in stem cell therapeutics; and Twelve baby, a cord blood bank that extracts and stores cord blood from babies for use in hematopoietic cell transplantation and other incurable diseases. In addition, it is involved in the bio-based business, including the provision of technology consulting and research, and cell production and quality control services; development and sale of media used in the extraction and proliferation of stem cells; and medical equipment development. Further, the company develops various chemical products, such as nucleosides/DMT protected nucleosides for use in oligonucleotides; mPEG/multi-arm PEG derivatives for use in pegylated drugs; and flame retardant chemicals for use in polyester fibers and epoxy resins, as well as pharmaceutical intermediates. Additionally, it develops cosmetics using stem cell technologies; and sells lab devices. PHARMICELL Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea.

Founded in 1968

pharmicell co ltd (005690) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

pharmicell co ltd (005690) Key Developments

Pharmicell Co., Ltd., Annual General Meeting, Mar 27, 2015

Pharmicell Co., Ltd., Annual General Meeting, Mar 27, 2015., at 09:00 Korea Standard Time. Location: Jungwon-gu, Seongnam, Gyeonggi dunchon 332 CC. Agenda: To consider audit reports, sales reports, external audit reports; to approve financial statements; to consider appointment of directors; to approve articles remuneration of directors; and to consider other issues.

Pharmicell Co., Ltd. Presents at HSBC Asia Investor Forum - Boston, Nov-20-2014

Pharmicell Co., Ltd. Presents at HSBC Asia Investor Forum - Boston, Nov-20-2014 . Venue: Boston, Massachusetts, United States.

Pharmicell Co., Ltd.(KOSE:A005690) dropped from KOSPI 200 Index

Pharmicell Co., Ltd. will be removed from the KOSPI 200 Index.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
005690:KS 5,250.00 KRW -40.00

005690 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 005690.
View Industry Companies
 

Industry Analysis

005690

Industry Average

Valuation 005690 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 8.5x
Price/Book 2.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 9.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMICELL CO LTD, please visit www.pharmicell.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.